abstract |
The invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds are characterized by structural formula IA as defined herein. The invention also relates to pharmaceutical compositions containing them and their use in the treatment of diseases or disorders associated with orexin-1 receptor activity |